Step therapy, sometimes called fail-first coverage, is a cost-control tool used by Medicare Part D plans and Medicare Advantage plans that requires you to try one or more alternative medications before your plan will cover the drug your physician originally prescribed. The idea is that lower-cost alternatives should be tried first when they may be equally effective. The frustration is that physicians prescribe specific drugs for specific reasons, and the plan's step therapy requirement may conflict with clinical judgment. Understanding how step therapy works and how to obtain an exception is essential for anyone who has had a prescription denied for this reason.
Step therapy is one of the most frustrating things I help clients navigate. Your doctor prescribes a medication that works, and the plan requires you to fail on a cheaper option first. The exception process works when your physician documents specifically why the required alternatives are contraindicated or have already failed. Do not just accept the denial, file the exception request with detailed documentation, and ask your doctor to request a peer-to-peer with the plan's medical director at the same time.
What step therapy is and why plans use it
Step therapy protocols require that you try a preferred (usually lower-cost) medication before the plan will cover a non-preferred or higher-tier medication. For example, a plan might require that you try two generic ACE inhibitors before it will cover a brand-name ARB your cardiologist prescribed. Or that you try a first-generation antidepressant before covering a newer SSRI. Plans implement these requirements to encourage use of lower-cost alternatives that may be clinically similar for many patients. The issue arises when the alternative is not appropriate for your specific situation.
Step therapy for Part B drugs in Medicare Advantage
A 2018 CMS rule expanded step therapy to include Part B drugs administered in a physician's office under Medicare Advantage plans. This means that specialty drugs given by infusion, biologic medications for conditions like rheumatoid arthritis, Crohn's disease, or cancer, can also be subject to step therapy requirements under Advantage plans. Before 2018, this was not permitted. Original Medicare does not use step therapy, your physician's prescription is honored without a required prior trial of alternatives.
The exception request process
When step therapy blocks coverage of a prescribed drug, you can request a step therapy exception (sometimes called a coverage determination or formulary exception). You must demonstrate that the required alternative drugs are not appropriate for your specific situation. Valid bases for an exception include the required drugs are contraindicated for you due to allergy, interaction, or medical condition; you have already tried the required drugs and they failed (prior documented treatment failure); the required drugs would cause an adverse reaction based on your medical history; or the required trial would take an unreasonably long time given the urgency of your condition.
Timeframes for exception decisions
Plans must respond to step therapy exception requests within specific timeframes. Standard requests for non-urgent situations must receive a decision within 72 hours for Part D and within 14 days for Part B drugs under Advantage. Expedited requests, where the standard timeframe would seriously jeopardize your health, must be decided within 24 hours for Part D and within 72 hours for Part B drugs. If the urgency of your medical situation justifies expedited review, your physician should request that designation when submitting the exception request.
Having a medication blocked by step therapy and not sure how to fight it?
Step therapy exceptions succeed when the physician documentation is specific and directly addresses the denial reason. I can help you understand the process and what your plan requires to approve the exception.
Book a Free CallBuilding a successful exception request
The most important element of a step therapy exception is strong physician documentation. Your prescribing physician should provide a detailed letter explaining the specific clinical rationale for the prescribed drug, why the required alternatives are inappropriate for your specific patient history, and any prior treatment failures or contraindications. Generic letters citing general patient preference do not succeed; specific clinical documentation addressing your exact circumstances does. Reference your complete medication history, documented side effects from alternatives if applicable, and any relevant guidelines that support the prescribed treatment.
Appealing a denied exception
If your step therapy exception is denied, you have full Medicare appeal rights at all five levels of the appeals process. At the first appeal level, redetermination or IRE reconsideration, submit additional clinical documentation if available. If your physician has not yet requested a peer-to-peer review with the plan's medical director, request one simultaneously with the formal appeal. The peer-to-peer conversation between physicians resolves many cases that formal appeals do not, particularly when the prescribing physician can speak directly to clinical specifics.